|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00512 GRAND PHARMA
Nominal 
9.450 +0.050 (+0.532%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
2
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 70.49 HKD (cts) | |
| Net Profit | 2,468.38 HKD (MIL) | DPS | 26.00 HKD (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (HKD (MIL)) |
EPS/ ((LPS)(HKD (cts)) |
DPS (HKD (cts)) |
Net Asset Value per Share (HKD) |
Highest (HKD (MIL)) |
Lowest (HKD (MIL)) |
| 2025 | 2,125.50 | 60.00 | 23.93 | -- | 2,131.00 | 2,120.00 |
| 2026 | 2,284.50 | 64.50 | 25.65 | -- | 2,334.00 | 2,235.00 |
| 2027 | 2,681.00 | 76.00 | 30.18 | -- | 2,681.00 | 2,681.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (HKD (MIL)) |
EPS*/ (LPS) (HKD (cts)) |
DPS * (HKD (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 2,120.00 | 60.00 | 23.86 | HUATAI FIN HLDGS HK | Buy | 10.15 | 19/05/2025 | |
| 2025 | 2,131.00 | 60.00 | 24.00 | CICC | OutPerform | 9.60 | 13/05/2025 | |
| 2026 | 2,334.00 | 66.00 | 26.30 | HUATAI FIN HLDGS HK | -- | -- | 19/05/2025 | |
| 2026 | 2,235.00 | 63.00 | 25.00 | CICC | -- | -- | 13/05/2025 | |
| 2027 | 2,681.00 | 76.00 | 30.18 | HUATAI FIN HLDGS HK | -- | -- | 19/05/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 24/07/2025 17:41 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |